These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19891570)

  • 1. Early experience with high-dosage daptomycin for prosthetic infections.
    De Rosa FG; Mollaretti O; Cometto C; Pagani N; Montrucchio C; Di Perri G
    Clin Infect Dis; 2009 Dec; 49(11):1772-3. PubMed ID: 19891570
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
    Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S
    Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with daptomycin in an infectious diseases service over 1 year: utility in an outpatient parenteral antibiotic programme.
    Seaton RA; Macconnachie AA
    Int J Antimicrob Agents; 2008 May; 31(5):492-7. PubMed ID: 18313274
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
    Corona Pérez-Cardona PS; Barro Ojeda V; Rodriguez Pardo D; Pigrau Serrallach C; Guerra Farfán E; Amat Mateu C; Flores Sanchez X
    J Antimicrob Chemother; 2012 Jul; 67(7):1749-54. PubMed ID: 22511636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
    Rao N; Regalla DM
    Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 8. Daptomycin.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18095389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic pneumonia induced by daptomycin.
    Hayes D; Anstead MI; Kuhn RJ
    J Infect; 2007 Apr; 54(4):e211-3. PubMed ID: 17207858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of high-dose daptomycin (>6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram-positive bacteria.
    Perrottet N; Steinrücken J; Chan M; Pannatier A; Borens O; Yusuf E; Trampuz A
    Int J Antimicrob Agents; 2015 Oct; 46(4):480-2. PubMed ID: 26235888
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.
    Herrera S; Sorlí L; Horcajada JP
    Med Clin (Barc); 2017 Sep; 149(5):223-224. PubMed ID: 28602211
    [No Abstract]   [Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
    Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
    Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin: evaluation of a high-dose treatment strategy.
    Wu G; Abraham T; Rapp J; Vastey F; Saad N; Balmir E
    Int J Antimicrob Agents; 2011 Sep; 38(3):192-6. PubMed ID: 21549573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin for Children in Clinical Practice Experience.
    Garazzino S; Castagnola E; Di Gangi M; Ortolano R; Krzysztofiak A; Nocerino A; Esposito S; D'Argenio P; Galli L; Losurdo G; Calitri C; Tovo PA;
    Pediatr Infect Dis J; 2016 Jun; 35(6):639-41. PubMed ID: 26910590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.
    Arbeit RD; Maki D; Tally FP; Campanaro E; Eisenstein BI;
    Clin Infect Dis; 2004 Jun; 38(12):1673-81. PubMed ID: 15227611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract]   [Full Text] [Related]  

  • 19. Daptomycin: rationale and role in the management of skin and soft tissue infections.
    Seaton RA
    J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.